ViroCell Biologics Revenue and Competitors
Estimated Revenue & Valuation
- ViroCell Biologics's estimated annual revenue is currently $14.9M per year.
- ViroCell Biologics's estimated revenue per employee is $155,000
- ViroCell Biologics's total funding is $165M.
Employee Data
- ViroCell Biologics has 96 Employees.
- ViroCell Biologics grew their employee count by 10% last year.
ViroCell Biologics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer, Co-Founder | Reveal Email/Phone |
2 | Chief Scientific Officer & Co-Founder | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | VP Corporate Development and Strategy | Reveal Email/Phone |
5 | VP, Business Development | Reveal Email/Phone |
6 | Manufacturing Officer | Reveal Email/Phone |
7 | Officer, Manufacturing | Reveal Email/Phone |
8 | Head Supply Chain | Reveal Email/Phone |
9 | SVP Quality | Reveal Email/Phone |
10 | Manufacturing officer | Reveal Email/Phone |
ViroCell Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | -12% | N/A | N/A |
#2 | $16.3M | 105 | 4% | N/A | N/A |
#3 | $107.2M | 494 | 25% | $292M | N/A |
#4 | $2.6M | 830 | 30% | $631.7M | N/A |
#5 | $18.1M | 117 | -8% | $81M | N/A |
#6 | $1.2M | 271 | 12% | $440M | N/A |
#7 | $54.6M | 282 | 0% | $132.9M | N/A |
#8 | $9.3M | 60 | -37% | N/A | N/A |
#9 | $21.2M | 137 | 12% | N/A | N/A |
#10 | $408.2M | 1646 | 11% | £994.6M | N/A |
What Is ViroCell Biologics?
ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.
keywords:N/A$165M
Total Funding
96
Number of Employees
$14.9M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.5M | 96 | 41% | N/A |
#2 | $20.2M | 96 | 32% | N/A |
#3 | $14.4M | 96 | 5% | N/A |
#4 | $24.3M | 96 | 66% | N/A |
#5 | $13.9M | 96 | -19% | N/A |